AtriCure, Inc.
ATRC
$37.66
$1.935.40%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 136.14M | 123.62M | 124.28M | 115.91M | 116.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 136.14M | 123.62M | 124.28M | 115.91M | 116.27M |
| Cost of Revenue | 34.66M | 30.99M | 31.66M | 29.12M | 29.43M |
| Gross Profit | 101.48M | 92.63M | 92.62M | 86.79M | 86.84M |
| SG&A Expenses | 78.39M | 76.05M | 72.19M | 73.24M | 73.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 142.33M | 129.57M | 138.80M | 123.32M | 123.44M |
| Operating Income | -6.19M | -5.95M | -14.52M | -7.41M | -7.17M |
| Income Before Tax | -5.93M | -6.51M | -15.30M | -7.53M | -7.76M |
| Income Tax Expenses | 261.00K | 239.00K | 266.00K | 322.00K | 253.00K |
| Earnings from Continuing Operations | -6.19M | -6.75M | -15.57M | -7.85M | -8.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.19M | -6.75M | -15.57M | -7.85M | -8.01M |
| EBIT | -6.19M | -5.95M | -14.52M | -7.41M | -7.17M |
| EBITDA | -1.02M | -870.00K | -9.70M | -2.48M | -2.64M |
| EPS Basic | -0.13 | -0.14 | -0.33 | -0.17 | -0.17 |
| Normalized Basic EPS | -0.08 | -0.09 | -0.20 | -0.10 | -0.10 |
| EPS Diluted | -0.13 | -0.14 | -0.33 | -0.17 | -0.17 |
| Normalized Diluted EPS | -0.08 | -0.09 | -0.20 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 47.72M | 47.39M | 47.13M | 47.11M | 46.91M |
| Average Diluted Shares Outstanding | 47.72M | 47.39M | 47.13M | 47.11M | 46.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |